Puberty Blockers

John Glen Excerpts

Tuesday 23rd June 2026 Commons Chamber

[John Glen (Salisbury) (Con)]

I acknowledge the serious way that the Secretary of State is approaching this. I think many people will be concerned that, as the shadow Minister has said, there is no objective blood marker for these individuals; I think they will be concerned that a group of people will be taken forward in this trial when a whole range of influences could have governed how they have got to that point, given that the implications of taking these drugs are quite profound for their life and further development. How does one reconcile the fact that there is no way of verifying the suitability and the way that these individuals have been selected for the trial? Perhaps he could help me to understand it better.

[James Murray]

I thank the right hon. Gentleman for the tone he took in asking an important question, which I am pleased to be able to respond to. The bar for getting on to this trial is set extremely high, with strict eligibility criteria: parental consent, alongside the young person themselves consenting or assenting; a diagnosis of gender incongruence for at least two years; and consent from both the NHS care team and a national multidisciplinary team, including a wide range of disciplines, to understand all aspects of a young person’s health, context and situation. The level of approvals and scrutiny that young people will have to go through to participate in the trial will, therefore, set the bar extremely high.